SCHEMBL4613656

SCHEMBL4613656

C=CCOC(=O)N1CC[N]CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43
GPR119 Q8TDV5 1/20 0.38
SLC6A15 Q9H2J7 1/20 0.37
ERN1 O75460 7/20 0.35
TSHR P16473 2/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4195614 0.82 LMNA (0.46) LMNAMAPK1RAB9AGPR119SLC6A15
SCHEMBL3992214 0.81 LMNA (0.45) LMNAMAPK1RAB9AGPR119SLC6A15
SCHEMBL3997516 0.81 LMNA (0.45) LMNAMAPK1RAB9AGPR119SLC6A15
SCHEMBL2985134 0.78 LMNA (0.46) LMNAMAPK1RAB9AGPR119SLC6A15
SCHEMBL9342278 0.78 MAPK1 (0.46) LMNAMAPK1RAB9ASLC6A15TSHR
SCHEMBL8665411 0.78 TSHR (0.59) LMNAMAPK1RAB9AGPR119TSHR
SCHEMBL1780077 0.78 LMNA (0.43) LMNAMAPK1RAB9AGPR119SLC6A15
SCHEMBL597800 0.76 LMNA (0.45) LMNAMAPK1RAB9AGPR119SLC6A15
SCHEMBL12551267 0.76 RAB9A (0.42) LMNAMAPK1RAB9AGPR119SLC6A15
Hydrochloric Acid SCHEMBL20488405 0.76 LMNA (0.42) LMNAMAPK1RAB9AGPR119SLC6A15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373234-B1 UROKINASE INHIBITORS WILEX AG (DE) 2008-02-13 EP disclosed
US-6861435-B2 Urokinase inhibitors PENTAPHARM AG (CH) 2005-03-01 US disclosed